Browsing byAuthorMalyla, V

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 11 to 20 of 20< previous 
Issue DateTitleAuthor(s)
2019-10-01Identification of biomarkers and genetic approaches toward chronic obstructive pulmonary diseaseWadhwa, R; Aggarwal, T; Malyla, V; Kumar, N; Gupta, G; Chellappan, DK; Dureja, H; Mehta, M; Satija, S; Gulati, M; Maurya, PK; Collet, T; Hansbro, PM; Dua, K
2019-02-01Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systemsDua, K; Malyla, V; Singhvi, G; Wadhwa, R; Krishna, RV; Shukla, SD; Shastri, MD; Chellappan, DK; Maurya, PK; Satija, S; Mehta, M; Gulati, M; Hansbro, N; Collet, T; Awasthi, R; Gupta, G; Hsu, A; Hansbro, PM
2019-11-01Investigating the Pathogenesis of Early Stage Squamous Cell Lung Carcinoma Using Murine ModelsSahu, P; Donovan, C; Pickles, S; Chimankar, V; Shukla, S; Gomez, H; Budden, K; Malyla, V; Paudel, KR; Dua, K; Hansbro, P
2019-11-01Investigating the Use of Mitochondria-Targeted H2S Donors for the Treatment of NSCLCPickles, S; Donovan, C; Chimankar, V; Sahu, P; Malyla, V; Tu, X; Gomez, H; Budden, K; Dua, K; Rahman, A; Whiteman, M; Hansbro, PM
2023-11Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticlesDe Rubis, G; Paudel, KR; Raju Allam, VSR; Malyla, V; Subramaniyan, V; Singh, SK; Panth, N; Gupta, G; Hansbro, PM; Chellappan, DK; Dua, K
2020-03-16Recent advances in experimental animal models of lung cancer.Malyla, V; Paudel, KR; Shukla, SD; Donovan, C; Wadhwa, R; Pickles, S; Chimankar, V; Sahu, P; Bielefeldt-Ohmann, H; Bebawy, M; Hansbro, PM; Dua, K
2020Role of lung microbiome in innate immune response associated with chronic lung diseasesPaudel, KR; Dharwal, V; Patel, V; Galvao, I; Wadhwa, R; Malyla, V; Shen, S; Budden, KF; Hansbro, N; Bebawy, M; Dua, K; Hansbro, P
2020-09-24Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.Mehta, M; Satija, S; Paudel, KR; Malyla, V; Kannaujiya, VK; Chellappan, DK; Bebawy, M; Hansbro, PM; Wich, PR; Dua, K
2022-02Unravelling the molecular mechanisms underlying chronic respiratory diseases for the development of novel therapeutics via in vitro experimental modelsTan, CL; Chan, Y; Candasamy, M; Chellian, J; Madheswaran, T; Sakthivel, LP; Patel, VK; Chakraborty, A; MacLoughlin, R; Kumar, D; Verma, N; Malyla, V; Gupta, PK; Jha, NK; Thangavelu, L; Devkota, HP; Bhatt, S; Prasher, P; Gupta, G; Gulati, M; Singh, SK; Paudel, KR; Hansbro, PM; Oliver, BG; Dua, K; Chellappan, DK
2019-11-01Using Experimental Mouse Models to Understand the Pathogenesis of Lung AdenocarcinomaChimankar, V; Pickles, S; Donovan, C; Sahu, P; Rahman, A; Gomez, H; Malyla, V; Bielefeldt-Ohmann, H; Wark, P; Watkins, N; Hansbro, PM